Status:
COMPLETED
Safety Study of Atomoxetine and Cerebrovascular Outcomes
Lead Sponsor:
Eli Lilly and Company
Collaborating Sponsors:
i3 Drug Safety
Conditions:
Cerebrovascular Accident
Transient Ischemic Attack
Eligibility:
All Genders
18+ years
Brief Summary
Using a proprietary insurance health claims database, Eli Lilly and Company has contracted with an external party to conduct a retrospective cohort study of health claims for the time period from 1 Ja...
Eligibility Criteria
Inclusion
- patients 18 years or older
- received dispensing of one of the study medications during the time period of the study (January 1, 2003 - December 31, 2006)
- 6 months of continuous enrollment prior to first dispensing
Exclusion
- presence of pre-existing arrhythmia and heart failure during the baseline period
Key Trial Info
Start Date :
January 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2008
Estimated Enrollment :
72000 Patients enrolled
Trial Details
Trial ID
NCT00634439
Start Date
January 1 2008
End Date
September 1 2008
Last Update
September 15 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician
Indianapolis, Indiana, United States